Bayer weighs break-up options as management job cuts loom

bayer-weighs-break-up-options-as-management-job-cuts-loom
Bayer weighs break-up options as management job cuts loom

Bayer is considering separating its consumer health or crop science divisions, according to the company’s new CEO, Bill Anderson. The goal is to revive the company’s share price, which has been struggling. The management is exploring the possibility of separating either the non-prescription medicines business or the agriculture business from the rest of the group. Anderson also mentioned that a sequential split into three companies is an option, as is keeping all three divisions intact. Further details will be provided at a capital markets day in March next year.

In addition to the potential separation, Bayer also plans to remove several layers of management to streamline decision-making and reduce the workforce. This move confirms a previous RushHourDaily report from September. Anderson believes that the current 12 layers of management between him and customers are excessive.

Bayer’s shares initially rose in response to the news but later fell by 1%. Analysts are weighing the company’s cautious guidance on business in 2024 against the possibility of an organizational turnaround. Bayer expects challenges to profitability in the coming year but remains confident in its 2023 financial guidance, emphasizing the need for a strong fourth quarter.

The potential separation of Bayer’s consumer health division is seen as a way to generate value and follow an industry trend. Other major drugmakers, such as Johnson & Johnson, GSK, Pfizer, and Sanofi, have already split off their consumer products units. Bayer’s agriculture, prescription drugs, and consumer health care units accounted for different percentages of the company’s 2022 group sales.

Anderson, who took over as CEO in June, is under pressure to boost Bayer’s shares, which have underperformed compared to its peers. He has promised to thoroughly review the company and explore all options. His appointment was well-received by shareholders, but some investors are urging him to act quickly to address the share price slump.

Bayer’s shares have been trading at a significant discount compared to its competitors in agriculture, pharmaceuticals, and consumer health activities. This is partly due to a preference among financial investors for pure-play companies. The company is also facing lawsuits over the alleged carcinogenic effect of its Roundup weedkiller, which has further impacted its stock performance.

In the third quarter, Bayer reported a 31% decline in earnings before interest, tax, depreciation, and amortization (EBITDA), adjusted for one-off effects. The lower earnings were primarily driven by the crop science division. The company also recorded a net loss for the quarter due to impairment charges at the crop science unit.

Overall, Bayer is exploring various options to improve its financial performance and share price. The potential separation of divisions and the streamlining of management are key steps in this process. The company aims to create maximum value and address the challenges it faces in the coming years.

About News Team

Hi, I'm Alex Perez, an experienced writer with a focus on lifestyle and culture news. From food and fashion to travel and entertainment, I love exploring the latest trends and sharing my insights with readers. I also have a strong interest in world news and business, and enjoy covering breaking stories and events.

Have a tip we should know? tips@rhd.news

Most Read

  1. News
    Pandora Papers Financial Leak Shows Us the Secrets of the World’s Rich and Powerful
    3 years ago
  2. Health
    US Supreme Court Rejects J & J TALC Cancer Case Appeal
    3 years ago
  3. Lifestyle
    9 Habits that Drain your Daily Focus and How to Avoid Them
    3 years ago
  4. BUSINESS
    Women’s Demand for Shapewear – the big Trends
    3 years ago
  5. BUSINESS
    Valentino Launches its Cosmetics Line
    3 years ago
  6. Health
    US Promises to Share 60 million Doses of AstraZeneca Vaccines
    3 years ago
  7. Health
    UK Offers Aid Amid Surging COVID-19 Cases in India
    3 years ago
  8. Sports
    Thousands of fans welcome Charlton funeral cortege at Old Trafford
    8 months ago
  9. News
    Brit left fighting for life after train derails in Argentinia
    8 months ago
  10. BUSINESS
    Dubai faces down airline rivals with $50 bln jet orders
    8 months ago
  11. Sunak
    UK’s Sunak brings back Cameron, sacks Braverman
    8 months ago
  12. Sports
    Man United’s Hojlund, Eriksen withdrawn from Denmark team duty
    8 months ago
  13. Health
    Autumn Sneezing Syndrome is on the rise… here’s what you can do
    8 months ago
  14. Canada
    Canada beat Italy to win Billie Jean King Cup for first time
    8 months ago

Follow @rushhourdaily: